搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
medtechdive
5 小时
Embecta to cut 125 jobs after ending insulin patch pump
Embecta said its patch pump would require additions to be commercially competitive, and plans to use the funds saved to pay down debt.
来自MSN
11 个月
World's first 'oral insulin patch' for diabetes could save patients having to inject
A London scientist is working on the world’s first oral insulin patch that could save diabetes patients from having to regularly inject the drug. Dr Hend Abdelhakim, an assistant professor at ...
pharmaphorum
11 小时
Insulin pump firm Insulet wins $452m in trade secrets clash
The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create ...
lifesciencesipreview
1 天
EOFlow ordered to pay rival $452m over insulin patch trade secrets
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with ...
STAT
23 小时
Insulet wins trade secret case against Korean insulin pump maker
Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on ...
drugdeliverybusiness
10 天
Embecta discontinues insulin patch pump program, plans restructuring
Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
drugdeliverybusiness
1 天
Embecta to lay off 118 in Massachusetts following patch pump program discontinuation
Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees.
medtechdive
10 天
Embecta discontinues insulin patch pump development
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...
FierceBiotech
1 天
Insulet nets $452M in damages from insulin pump rival EOFlow in trade secrets suit
The Massachusetts district court awarded Insulet a total of $452 million, including $170 million in compensation plus $282 ...
9 天
Embecta to discontinue insulin patch pump program, initiates restructuring plan
Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...
2 天
New Initiatives Expected To Make Embecta More Profitable
Embecta Corp.'s Q4 results showed significant net income and EPS growth. Embecta also announced a restructuring plan. See why ...
usaherald
1 天
Insulet Wins $452M Jury Verdict in Trade Secrets Battle with EOFlow
Insulet Corp., a Massachusetts-based medical device company, secured a staggering $452 million jury verdict against South ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈